Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Jiadi Gan"'
Autor:
Jiaxuan Wu, Ruicen Li, Jiadi Gan, Qian Zheng, Guoqing Wang, Wenjuan Tao, Ming Yang, Wenyu Li, Guiyi Ji, Weimin Li
Publikováno v:
Thoracic Cancer, Vol 15, Iss 28, Pp 2061-2072 (2024)
Abstract Background With the rapid increase of chest computed tomography (CT) images, the workload faced by radiologists has increased dramatically. It is undeniable that the use of artificial intelligence (AI) image‐assisted diagnosis system in cl
Externí odkaz:
https://doaj.org/article/42fdcc25253642bc91a1dcc789e81d04
Autor:
Wenxin Luo, Jiadi Gan, Zhu Luo, Shuangqing Li, Zhoufeng Wang, Jiaxuan Wu, Huohuo Zhang, Jinghong Xian, Ruixin Cheng, Xiumei Tang, Yi Liu, Ling Yang, Qianqian Mou, Xue Zhang, Yi Chen, Weiwen Wang, Yantong Wang, Lin Bai, Xuan Wei, Rui Zhang, Lan Yang, Yaxin Chen, Li Yang, Yalun Li, Dan Liu, Weimin Li, Lei Chen
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 9, Iss 1, Pp 1-9 (2024)
Abstract Vaccines have proven effective in protecting populations against COVID-19, including the recombinant COVID-19 vaccine (Sf9 cells), the first approved recombinant protein vaccine in China. In this positive-controlled trial with 85 adult parti
Externí odkaz:
https://doaj.org/article/138689dfddb048758ec08ca079f6f8b5
Publikováno v:
MedComm, Vol 5, Iss 1, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/c8c279ec37c84230bf50f49043239911
Autor:
Dongcheng Liu, Hongguang Liu, Jiadi Gan, Shinuan Zeng, Fuhua Zhong, Bin Zhang, Zhe Zhang, Siyu Zhang, Lu Jiang, Guangsuo Wang, Yixin Chen, Feng-Ming Spring Kong, Wenfeng Fang, Lingwei Wang
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Non-small cell lung carcinoma (NSCLC) patients who initially received tyrosine kinase inhibitor (TKI) therapy often acquired resistance via multiple complex mechanisms. The amplification of FGF3/4/19/CCND1 on chromosome 11q13 was found in many cancer
Externí odkaz:
https://doaj.org/article/51ac84481c534c0c9e2c578496ce2004
Autor:
Jun Liao MD, Yihua Huang MD, Jiadi Gan MD, Lanlan Pang MD, Wael A. S. Ali MD, Yunpeng Yang MD, PhD, Likun Chen MD, PhD, Li Zhang MD, PhD, Wenfeng Fang MD, PhD
Publikováno v:
Cancer Control, Vol 29 (2022)
Objectives Osimertinib has exhibited promising central nervous system (CNS) efficacy in Epidermal growth factor receptor (EGFR)-mutated advanced non-small-cell lung cancer (NSCLC) patients. In real-world clinical practice, patients would turn to plas
Externí odkaz:
https://doaj.org/article/d1e38e447b23445688e51e6e5de5c752
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Externí odkaz:
https://doaj.org/article/6e6aa5e6110f41a0a96b4a2a77d081da
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Immune checkpoint inhibitors (ICIs) have come to play an increasingly prominent role in the treatment of lung cancer, and some are recommended as a first-line treatment for late-stage non-small-cell lung cancer, either as a monotherapy or in combinat
Externí odkaz:
https://doaj.org/article/a601b945c677439d959883db5fe8c11c
Autor:
Wenfeng Fang, Yihua Huang, Shaodong Hong, Zhonghan Zhang, Minghui Wang, Jiadi Gan, Wenjing Wang, Honglin Guo, Kai Wang, Li Zhang
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Epidermal growth factor receptor exon 20 insertion (EGFRex20ins) mutations represent approximately 4–12% of EGFR mutations and are generally refractory to the 1st and 2nd generation EGFR tyrosine kinase inhibitors (TKIs). Develo
Externí odkaz:
https://doaj.org/article/f7ec4d72ccd84002a295283e066a1362
Autor:
Yihua, Huang, Chunwei, Xu, Yuanliang, Sun, Wenxian, Wang, Xingya, Li, Jun, Liao, Lanlan, Pang, Liang, Zeng, Juan, Li, Xihua, Wang, Qi, Zhang, Zhanhong, Xie, Lin, Xiao, Jiadi, Gan, Wenfeng, Fang
Publikováno v:
Lung Cancer. 172:117-123
Currently, whether patients with rare epidermal growth factor receptor (EGFR) mutations could benefit from EGFR tyrosine kinase inhibitors (TKIs) demands further studies. Limited clinical data are available regarding the molecular characteristics and
Autor:
Yihua Huang, Jun Liao, Jiadi Gan, Lan-Lan Pang, Zhaodi Yuan, Yi Lv, Kailang Zhang, Li Zhang, Wenfeng Fang
Publikováno v:
SSRN Electronic Journal.